Grzegorz S Nowakowski, MD

  • 4187 Citations
  • 40 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2001 2019

  • 4187 Citations
  • 40 Scopus h-Index
  • 126 Article
  • 7 Review article
  • 3 Letter
  • 1 Comment/debate
2001
72 Citations (Scopus)

The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells

Berrios, V. M., Dooner, G. J., Nowakowski, G. S., Frimberger, A., Valinski, H., Quesenberry, P. J. & Becker, P. S., 2001, In : Experimental Hematology. 29, 11, p. 1326-1335 10 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
CD31 Antigens
L-Selectin
Cytokines
Laminin
2002
6 Citations (Scopus)

Epilepsia partialis continua as an atypical presentation of cat scratch disease in a young adult

Nowakowski, G. S. & Katz, A., Dec 10 2002, In : Neurology. 59, 11, p. 1815-1816 2 p.

Research output: Contribution to journalArticle

Epilepsia Partialis Continua
Technetium Tc 99m Exametazime
Cat-Scratch Disease
X Ray Computed Tomography
Partial Epilepsy
2004
56 Citations (Scopus)

A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells

Nowakowski, G. S., Dooner, M. S., Valinski, H. M., Mihaliak, A. M., Quesenberry, P. J. & Becker, P. S., 2004, In : Stem Cells. 22, 6, p. 1030-1038 9 p.

Research output: Contribution to journalArticle

Peptide Library
Hematopoietic Stem Cells
Bone Marrow
Peptides
Stem Cells
2005
140 Citations (Scopus)

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

Nowakowski, G. S., Witzig, T. E., Dingli, D. M., Tracz, M. J., Gertz, M., Lacy, M., Lust, J. A., Dispenzieri, A., Greipp, P. R., Kyle, R. A. & Rajkumar, S. V., Oct 2005, In : Blood. 106, 7, p. 2276-2279 4 p.

Research output: Contribution to journalArticle

Flow cytometry
Plasma Cells
Multiple Myeloma
Flow Cytometry
Plasmas
27 Citations (Scopus)

Clinical significance of monoclonal B cells in cerebrospinal fluid

Nowakowski, G. S., Call, T. G., Morice, W. G., Kurtin, P. J., Cook, R. J. & Zent, C. S., Jan 2005, In : Cytometry Part B - Clinical Cytometry. 63, 1, p. 23-27 5 p.

Research output: Contribution to journalArticle

Cerebrospinal Fluid
B-Lymphocytes
Mantle-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Population
24 Citations (Scopus)
Thalidomide
Stem Cell Transplantation
Multiple Myeloma
Dexamethasone
Therapeutics
20 Citations (Scopus)

Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia

Nowakowski, G. S., Morice, W. G., Phyliky, R. L., Li, C. Y. & Tefferi, A., Feb 2005, In : British Journal of Haematology. 128, 4, p. 490-492 3 p.

Research output: Contribution to journalArticle

Large Granular Lymphocytic Leukemia
KIR Receptors
HLA Antigens
Hematopoiesis
Protein Isoforms
48 Citations (Scopus)

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia

Nowakowski, G. S., Dewald, G. W., Hoyer, J., Paternoster, S. F., Stockero, K. J., Fink, S. R., Smoley, S. A., McPhail, E., Phyliky, R. L., Call, T. G., Shanafelt, T. D., Kay, N. E. & Zent, C. S., Jul 2005, In : British Journal of Haematology. 130, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

Interphase
B-Cell Chronic Lymphocytic Leukemia
Fluorescence In Situ Hybridization
Mantle-Cell Lymphoma
Lymphocytosis
2006
97 Citations (Scopus)

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

Nowakowski, G. S., McCollum, A. K., Ames, M. M., Mandrekar, S. J., Reid, J. M., Adjei, A., Toft, D. O., Safgren, S. L. & Erlichman, C., Oct 15 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6087-6093 7 p.

Research output: Contribution to journalArticle

tanespimycin
Maximum Tolerated Dose
Neoplasms
Pharmacokinetics
Proteins
65 Citations (Scopus)

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

Shanafelt, T. D., Lee, Y. K., Call, T. G., Nowakowski, G. S., Dingli, D. M., Zent, C. S. & Kay, N. E., Jun 2006, In : Leukemia Research. 30, 6, p. 707-712 6 p.

Research output: Contribution to journalArticle

Tea
B-Cell Chronic Lymphocytic Leukemia
Polyphenols
Appointments and Schedules
Anecdotes
67 Citations (Scopus)
Stem Cell Transplantation
Multiple Myeloma
Cyclophosphamide
Intercellular Signaling Peptides and Proteins
Hematopoietic Stem Cell Mobilization
19 Citations (Scopus)

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia [9]

Shanafelt, T. D., Jelinek, D. F., Tschumper, R., Schwager, S., Nowakowski, G. S., DeWald, G. W. & Kay, N. E., Jul 1 2006, In : Journal of Clinical Oncology. 24, 19, p. 3218-3219 2 p.

Research output: Contribution to journalArticle

DNA Mutational Analysis
ZAP-70 Protein-Tyrosine Kinase
Immunoglobulin Heavy Chains
Chromosomal Instability
B-Cell Chronic Lymphocytic Leukemia
41 Citations (Scopus)
Cell Transplantation
Stem cells
Multiple Myeloma
Flow cytometry
Stem Cell Transplantation
117 Citations (Scopus)

Immunoglobulin free light chains and solitary plasmacytoma of bone

Dingli, D. M., Kyle, R. A., Rajkumar, S. V., Nowakowski, G. S., Larson, D. R., Bida, J. P., Gertz, M., Therneau, T. M., Melton, L. J., Dispenzieri, A. & Katzmann, J. A., Sep 15 2006, In : Blood. 108, 6, p. 1979-1983 5 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Plasmacytoma
Immunoglobulins
Bone
Light
91 Citations (Scopus)

Metastatic malignant melanoma of the gastrointestinal tract

Liang, K. V., Sanderson, S. O., Nowakowski, G. S. & Arora, A. S., 2006, In : Mayo Clinic Proceedings. 81, 4, p. 511-516 6 p.

Research output: Contribution to journalArticle

Gastrointestinal Tract
Melanoma
Neoplasm Metastasis
Deglutition Disorders
Stomach
20 Citations (Scopus)

Radioimmunotherapy for B-cell non-Hodgkin lymphoma

Nowakowski, G. S. & Witzig, T. E., Mar 2006, In : Clinical Advances in Hematology and Oncology. 4, 3, p. 225-231 7 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
B-Cell Lymphoma
Immunoconjugates
Non-Hodgkin's Lymphoma
Radioisotopes
2007
38 Citations (Scopus)

Relationship between depth of response and outcome in multiple myeloma

Dingli, D. M., Pacheco, J. M., Nowakowski, G. S., Kumar, S. K., Dispenzieri, A., Hayman, S. R., Lacy, M., Gastineau, D. A. & Gertz, M., Nov 1 2007, In : Journal of Clinical Oncology. 25, 31, p. 4933-4937 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Survival
Therapeutics
Transplantation
32 Citations (Scopus)

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: A universally available prognostic test

Nowakowski, G. S., Hoyer, J., Shanafelt, T. D., Geyer, S. M., LaPlant, B. R., Call, T. G., Jelinek, D. F., Zent, C. S. & Kay, N. E., 2007, In : Mayo Clinic Proceedings. 82, 4, p. 449-453 5 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Leukemia
Immunoglobulin Heavy Chain Genes
Vimentin
Lymphocytes
2008
33 Citations (Scopus)

Alternative splicing regulates activation-induced cytidine deaminase (AID): Implications for suppression of AID mutagenic activity in normal and malignant B cells

Wu, X., Darce, J. R., Chang, S. K., Nowakowski, G. S. & Jelinek, D. F., Dec 1 2008, In : Blood. 112, 12, p. 4675-4682 8 p.

Research output: Contribution to journalArticle

Alternative Splicing
B-Lymphocytes
Cells
Germinal Center
Genetic Recombination
106 Citations (Scopus)

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: A prognostic parameter with therapeutic potential

Shanafelt, T. D., Geyer, S. M., Bone, N. D., Tschumper, R. C., Witzig, T. E., Nowakowski, G. S., Zent, C. S., Call, T. G., LaPlant, B., Dewald, G. W., Jelinek, D. F. & Kay, N. E., Mar 2008, In : British Journal of Haematology. 140, 5, p. 537-546 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Observational Studies
Therapeutics
Fluorescence In Situ Hybridization

Gang of 3 in aggressive CLL?

Nowakowski, G. S., Jul 1 2008, In : Blood. 112, 1, p. 5-6 2 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients

Tschumper, R. C., Geyer, S. M., Campbell, M. E., Kay, N. E., Shanafelt, T. D., Zent, C. S., Nowakowski, G. S., Call, T. G., Dewald, G. W. & Jelinek, D. F., Jan 2 2008, In : Journal of Clinical Investigation. 118, 1, p. 306-315 10 p.

Research output: Contribution to journalArticle

Immunoglobulin Genes
B-Cell Chronic Lymphocytic Leukemia
Immunoglobulin Heavy Chain Genes
Mutation
Genes
6 Citations (Scopus)

Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells

Nowakowski, G. S., Mukhopadhyay, D., Wu, X. & Kay, N. E., Oct 2008, In : Leukemia Research. 32, 10, p. 1634-1636 3 p.

Research output: Contribution to journalArticle

Neuropilin-1
B-Cell Chronic Lymphocytic Leukemia
2009
52 Citations (Scopus)

Bi-directional activation between mesenchymal stem cells and CLL B-cells: Implication for CLL disease progression

Ding, W. D., Nowakowski, G. S., Knox, T. R., Boysen, J. C., Maas, M. L., Schwager, S. M., Wu, W., Wellik, L. E., Dietz, A. B., Ghosh, A. K., Secreto, C. R., Medina, K. L., Shanafelt, T. D., Zent, C. S., Call, T. G. & Kay, N. E., Nov 2009, In : British Journal of Haematology. 147, 4, p. 471-483 13 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Mesenchymal Stromal Cells
Disease Progression
Coculture Techniques
Up-Regulation
50 Citations (Scopus)

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

Nowakowski, G. S., Hoyer, J., Shanafelt, T. D., Zent, C. S., Call, T. G., Bone, N. D., Laplant, B., Dewald, G. W., Tschumper, R. C., Jelinek, D. F., Witzig, T. E. & Kay, N. E., Apr 10 2009, In : Journal of Clinical Oncology. 27, 11, p. 1844-1849 6 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Artifacts
Observational Studies
Blood Cells
1 Citation (Scopus)

Reply to R.S. Go

Nowakowski, G. S., Shanafelt, T. D., Schwager, S. & Kay, N. E., Aug 1 2009, In : Journal of Clinical Oncology. 27, 22

Research output: Contribution to journalArticle

2010
19 Citations (Scopus)

Chronic lymphoproliferative disorder of natural killer cells: A distinct entity with subtypes correlating with normal natural killer cell subsets

Morice, W. G., Jevremovic, D., Olteanu, H., Roden, A., Nowakowski, G. S., Kroft, S., Hanson, C. A. & Kurtin, P. J., Apr 2010, In : Leukemia. 24, 4, p. 881-884 4 p.

Research output: Contribution to journalArticle

NK Cell Lectin-Like Receptor Subfamily B
CD56 Antigens
KIR Receptors
Immunophenotyping
Lymphoproliferative Disorders
103 Citations (Scopus)

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M., 2010, In : Mayo Clinic Proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Guidelines
Therapeutics
Immunoglobulin M
Plasmapheresis
40 Citations (Scopus)
Lymphopenia
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Recurrence
Drug Therapy

Reply to C. Barker et al and H. Asai et al

Nowakowski, G. S., Maurer, M. J., Witzig, T. E. & Cerhan, J. R., Aug 20 2010, In : Journal of Clinical Oncology. 28, 24

Research output: Contribution to journalArticle

Reply to J.R. Carver et al.

Nowakowski, G. S., Witzig, T. E., Maurer, M. J. & Cerhan, J. R., Oct 20 2010, In : Journal of Clinical Oncology. 28, 30

Research output: Contribution to journalArticle

7 Citations (Scopus)

Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4+ T Cells

Wu, X., Tschumper, R. C., Gutierrez, A., Mihalcik, S. A., Nowakowski, G. S. & Jelinek, D. F., 2010, In : PLoS One. 5, 12, e15549.

Research output: Contribution to journalArticle

T-cells
Germinal Center
DNA repair
DNA Repair
B-lymphocytes
13 Citations (Scopus)

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

Shanafelt, T. D., Rabe, K. G., Kay, N. E., Zent, C. S., Call, T. G., Slager, S. L., Bowen, D. A., Schwager, S. M. & Nowakowski, G. S., Jul 2010, In : Leukemia and Lymphoma. 51, 7, p. 1233-1240 8 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
B-Cell Chronic Lymphocytic Leukemia
Anti-Inflammatory Agents
Pharmaceutical Preparations
Follicular Lymphoma
57 Citations (Scopus)

Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era

Nowakowski, G. S., Maurer, M. J., Habermann, T. M., Ansell, S. M., Macon, W. R., Ristow, K. M., Allmer, C., Slager, S. L., Witzig, T. E. & Cerhan, J. R., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 412-417 6 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Rituximab
Disease-Free Survival
150 Citations (Scopus)

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma

Drake, M. M., Maurer, M. J., Link, B. K., Habermann, T. M., Ansell, S. M., Micallef, I., Kelly, J. L., Macon, W. R., Nowakowski, G. S., Inwards, D. J., Johnston, P. B., Singh, R. J., Allmer, C., Slager, S. L., Weiner, G. J., Witzig, T. E. & Cerhan, J. R., Sep 20 2010, In : Journal of Clinical Oncology. 28, 27, p. 4191-4198 8 p.

Research output: Contribution to journalArticle

Vitamin D
Non-Hodgkin's Lymphoma
Disease-Free Survival
T-Cell Lymphoma
Survival
2011

Biological evaluation of CpG stimulation of normal human B-cells: Implications for B-cell biology and cytogenetic analysis of CLL B-cells

Wu, X., Smoley, S. A., Peterson, M. A., Walters, D. K., Arendt, B. K., Nowakowski, G. S., Van Dyke, D. L., Kay, N. E. & Jelinek, D. F., May 2011, In : British Journal of Haematology. 153, 3, p. 402-405 4 p.

Research output: Contribution to journalArticle

Karyotyping
CpG Islands
Cytogenetic Analysis
B-Cell Chronic Lymphocytic Leukemia
Cytogenetics
67 Citations (Scopus)
Integrin alpha4beta1
B-Cell Lymphoma
Mesenchymal Stromal Cells
Integrins
Apoptosis
50 Citations (Scopus)

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma

Maurer, M. J., Micallef, I., Cerhan, J. R., Katzmann, J. A., Link, B. K., Colgan, J. P., Habermann, T. M., Inwards, D. J., Markovic, S. N., Ansell, S. M., Porrata, L. F., Johnston, P. B., Nowakowski, G. S., Thompson, C. A., Gupta, M., Syrbu, S. I., Kurtin, P. J., Macon, W. R., Nikcevich, D. A. & Witzig, T. E., Apr 20 2011, In : Journal of Clinical Oncology. 29, 12, p. 1620-1626 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Light
Serum
Survival
81 Citations (Scopus)

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: Phase i study

Nowakowski, G. S., Laplant, B., Habermann, T. M., Rivera, C. E., MacOn, W. R., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Ansell, S. M., Klebig, R. R., Reeder, C. B. & Witzig, T. E., Dec 2011, In : Leukemia. 25, 12, p. 1877-1881 5 p.

Research output: Contribution to journalArticle

Vincristine
B-Cell Lymphoma
Prednisone
Doxorubicin
Cyclophosphamide
30 Citations (Scopus)

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Witzig, T. E., Tang, H., Micallef, I., Ansell, S. M., Link, B. K., Inwards, D. J., Porrata, L. F., Johnston, P. B., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Thompson, C. A., Allmer, C., Maurer, M. J., Gupta, M., Weiner, G., Hohl, R., Kurtin, P. J., Ding, H., Loegering, D. & 4 others, Schneider, P., Peterson, K., Habermann, T. M. & Kaufmann, S. H., Nov 3 2011, In : Blood. 118, 18, p. 4882-4889 8 p.

Research output: Contribution to journalArticle

tipifarnib
Farnesyltranstransferase
Refractory materials
Non-Hodgkin's Lymphoma
Lymphoma
114 Citations (Scopus)

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma

Wilcox, R. A., Ristow, K., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Colgan, J. P., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., Markovic, S. N. & Porrata, L., Sep 2011, In : Leukemia. 25, 9, p. 1502-1509 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Lymphocytes
Survival
2012
41 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Survival
Disease-Free Survival
27 Citations (Scopus)

Complement dependent cytotoxicity in chronic lymphocytic leukemia: Ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement

Baig, N. A., Taylor, R. P., Lindorfer, M. A., Church, A. K., Laplant, B. R., Pavey, E. S., Nowakowski, G. S. & Zent, C. S., Nov 2012, In : Leukemia and Lymphoma. 53, 11, p. 2218-2227 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Complement Activation
Complement Membrane Attack Complex
ofatumumab
alemtuzumab
13 Citations (Scopus)

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma

Ansell, S. M., Tang, H., Kurtin, P. J., Koenig, P. A., Nowakowski, G. S., Nikcevich, D. A., Nelson, G. D., Yang, Z., Grote, D. M., Ziesmer, S. C., Silberstein, P. T., Erlichman, C. & Witzig, T. E., May 2012, In : Leukemia. 26, 5, p. 1046-1052 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Follicular Lymphoma
T-Lymphocytes
Confidence Intervals
26 Citations (Scopus)

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma

Kelly, J. L., Drake, M. M., Fredericksen, Z. S., Asmann, Y., Liebow, M., Shanafelt, T. D., Feldman, A. L., Ansell, S. M., Macon, W. R., Herr, M. M., Wang, A. H., Nowakowski, G. S., Call, T. G., Habermann, T. M., Slager, S. L., Witzig, T. E. & Cerhan, J. R., Jul 2012, In : Cancer Causes and Control. 23, 7, p. 1017-1029 13 p.

Research output: Contribution to journalArticle

Solar System
Vitamin D
Non-Hodgkin's Lymphoma
Odds Ratio
Confidence Intervals
132 Citations (Scopus)

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

Porrata, L. F., Ristow, K., Colgan, J. P., Habermann, T. M., Witzig, T. E., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nowakowski, G. S., Thompson, C. A. & Markovic, S. N., Feb 1 2012, In : Haematologica. 97, 2, p. 262-269 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lymphocyte Count
Monocytes
Lymphocytes
Confidence Intervals
51 Citations (Scopus)
Hodgkin Disease
Monocytes
Lymphocytes
Survival
Confidence Intervals
81 Citations (Scopus)

Pulmonary langerhans cell histiocytosis.

Suri, H. S., Yi, E. S., Nowakowski, G. S. & Vassallo, R., 2012, In : Orphanet Journal of Rare Diseases. 7, p. 16 1 p.

Research output: Contribution to journalArticle

Langerhans Cell Histiocytosis
Lung
Immunosuppressive Agents
Thorax
Inflammation
64 Citations (Scopus)

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma

Wilcox, R. A., Ristow, K., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Colgan, J. P., Nowakowski, G. S., Ansell, S. M., Witzig, T. E., Markovic, S. N. & Porrata, L., Apr 2012, In : Leukemia and Lymphoma. 53, 4, p. 575-580 6 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Monocytes
Survival
Spontaneous Remission
Tumor Microenvironment
2013
17 Citations (Scopus)

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 2013, In : American Journal of Hematology. 88, 7, p. 589-593 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Oligodeoxyribonucleotides
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
B-Lymphocytes